iFANN
    搜索 iFANN...
    登录
    首页
    新闻
    视频
    图片
    GIF
    探索
    投票
    大奖
    iFAMOUS
    维基
    动漫
    聊天室
    通知
    私信
    收藏
    我的
    维基大奖iFAMOUS排行榜行业创作者奖励用户奖励条款隐私社区准则下架 / DMCA帮助开发者

    © 2026 iFANN

    首页
    搜索
    私信
    提醒
    我的

    帖子

    Polly Spring
    Polly Spring@polly_spring
    💭Science💭Health

    Supramolecular drugs and Alzheimer's research

    The brain has its own waste disposal setup, and dementia can jam it. That's the part a team led by the Institute for Bioengineering of Catalonia went after, and the lab numbers are hard to ignore. Their answer is nanoscale compounds they call "supramolecular drugs." They don't work like conventional meds. What they do is engage the systems controlling the blood-brain barrier, the protective layer that tends to break down in dementia, and the aim is to get its transport machinery working again so amyloid-beta proteins, the ones closely tied to cognitive decline, can be cleared out properly. In the lab, toxic protein levels fell fast, up to 60 percent within an hour of treatment. Then came the longer animal work with aged mice: several doses left their cognitive performance looking like that of much younger animals. Plaques aren't the direct target here. What's being repaired is the brain's clearance capacity at the vascular and cellular level, and that reframing could matter for how neurodegenerative disease gets treated going forward. The study is by Chen, J., Battaglia, G., et al., published in 2026 in Signal Transduction and Targeted Therapy.

    1w

    74 赞4 踩12 转发6 评论
    ?

    评论

    还没有评论。来抢沙发吧!

    帖子

    Polly Spring
    Polly Spring@polly_spring
    💭Science💭Health

    Supramolecular drugs and Alzheimer's research

    The brain has its own waste disposal setup, and dementia can jam it. That's the part a team led by the Institute for Bioengineering of Catalonia went after, and the lab numbers are hard to ignore. Their answer is nanoscale compounds they call "supramolecular drugs." They don't work like conventional meds. What they do is engage the systems controlling the blood-brain barrier, the protective layer that tends to break down in dementia, and the aim is to get its transport machinery working again so amyloid-beta proteins, the ones closely tied to cognitive decline, can be cleared out properly. In the lab, toxic protein levels fell fast, up to 60 percent within an hour of treatment. Then came the longer animal work with aged mice: several doses left their cognitive performance looking like that of much younger animals. Plaques aren't the direct target here. What's being repaired is the brain's clearance capacity at the vascular and cellular level, and that reframing could matter for how neurodegenerative disease gets treated going forward. The study is by Chen, J., Battaglia, G., et al., published in 2026 in Signal Transduction and Targeted Therapy.

    1w

    74 赞4 踩12 转发6 评论
    ?

    评论

    还没有评论。来抢沙发吧!